SMi's 2013 RNA Therapeutics conference will look to discuss and share some of the latest findings and research in the field of RNAi technologies and the delivery mechanisms by which these therapies are administered to their target tissues.A selection of distinguished speakers will look to provide the latest insights into some of the most promising technologies in RNAi development and delivery as well as addressing some of the current IP and regulatory challenges faced in the development and protection of these technologies.
Explore
Membership
